INTRODUCTION
Chemotaxis is believed to be an important mechanism by which polymorphonuclear leukocytes (PMN)' as D. E. Van Epps was the recipient of an Arthritis Fouindation Senior Investigatorship Award.
Received for publication 5 July 1979 and in revised form 26 (2) , cause cell aggregation (3), increase intracellular levels ofcyclic guanosine 5'-monophosphate (cGMP) (4) ; increase microtubule and microfilament assembly (5, 6) , stimulate degranulation (7) , increase adherence (6, 8) , and stimulate superoxide anion production (6, 9) . A recent study by Gallin et al. (10) has shown that under appropriate conditions, factors such as phorbol myristate acetate, concanavalin A (Con A), and the calcium ionophore A23187, which stimulate neutrophil secretion ofenzymes, increase adherence and alter the binding of the chemotactic peptide, f-Met-Leu-Phe (10) . All of these cited studies indicate that the neutrophils exposed to chemotactic stimuli or agents capable of stimulating degranulation undergo metabolic, cytoskeletal, and surface receptor alterations. The present study demonstrates that neutrophils that either have been exposed to a chemotactic stimulus or have migrated in response to this stimulus are functionally more active in systems measuring stimulated chemiluminescence, superoxide anion generation, and bactericidal activity than those that have not been exposed to chemotactic factor.
METHODS
Cell preparation. Human PMIN were prepared from heparinized peripheral blood by Ficoll-Hypaque centrifugation (11) . The cell pellet containing PMN and erythrocytes was resuspended in Hanks' balanced salt solution (HBSS) and mixed with Plasmagel (HTI, Buffalo, N. Y.) at a concentration of 1 HBSS supplemented with 5% fetal calf serum (FCS) to a concentration of 2 x 107 PMN/ml. This preparation contained > 90% neutrophils. The cell suspension was then divided into three parts and each was treated in one of the following ways: (a) one part was incubated at 37°C for 3 h in HBSS supplemented with 5% FCS; (b) one part was incubated at 37°C for 3 h in 5% FCS plus chemotactic factor; (c) the remaining cells in media supplemented with 5% FCS were placed in the upper compartment of an enlarged Boyden type chemotactic chamber (12) (1 ml/chamber) and allowed to migrate for 3 h at 37°C toward one of several chemotactic factors. In the third case, cells were obtained after they had responded to chemotactic factor and appeared in the lower compartment of the chemotactic chamber. In each case, cells were washed twice to remove media and chemotactic factor and tested in the appropriate assay. The three cell preparations represent (a) control cells, (b) cells exposed to chemotactic factor, and (c) cells that had actually migrated through a membrane in response to the same concentration of chemotactic factor.
Guinea pig peripheral blood and peritoneal exudate PMN were obtained from male, outbred, Hartley guinea pigs 4 h after an intraperitoneal injection of 10 ml of 50% caseinsaturated Eagle's Minimum Essential Media (Casein supplied by Fischer Scientific Co., Pittsburgh, Pa.). Casein preparations were centrifuged at 20,000 g for 20 min and filtered through a 0.22-gm pore-size filter to remove any particulate before injection. Peritoneal exudate cells were obtained by lavage using 100 ml of HBSS with 5 U of heparin/ml to wash the peritoneal cavity. The fluids were centrifuged and the cell pellet washed and resuspended to 1 x 107 cells/ml. Differential counts on these cells indicated that they contained >90% neutrophils. Peripheral blood was obtained by cardiac puncture from the same animal after peritoneal lavage. Blood was heparinized and PMN were prepared by Ficoll-Hypa(lue centrifugation followed by Plasmagel sedimentation of erythrocytes. Residual erythrocytes were lysed by a 30-s treatment with 4°C distilled water, and cells were resuspended to 1 x 107 cells/ml. Differential counts showed these preparations to contain >90% PMN. In each case, peritoneal exudate cells were treated for 30 s with distilled water for comparison with peripheral blood PMN where residual erythrocytes were similarly lysed.
Chemotactic factors. Three types of chemotactic factors were used in this study. The first was a mixture containing 50% casein-saturated minimum essential media and 10% fresh autologous normal serum. This preparation proved to be a potent chemotactic mixture and was the primary chemotactic factor used to attract large numbers of cells through the chemotaxis membrane. This mixture was found to be both chemotactic and chemokinetic as determined by titration experiments usinlg the leading front assay for chemotaxis (13) and by determining that maximal migration in the presence of a positive chemotactic gradient far exceeded the maximal chemokinetic response observed with no gradient present. The second factor used was a partially purified preparation of chemotactic C5 fragment obtained from fresh serum after its activation with zymosan (20 mng/ml zymosani for 60 mmin at 37°C). The chemotactic C5 fragment was obtained by passage of activated human serum over a Sephadex G-75 column. The low molecular weight fractions with chemotactic activity were concentrated by ultrafiltration, using a membrane permeable to molecules of <2,000 mol wt. This preparation was chemotactic for human PMN and its activity was 95% inhibitable with anti-human C5. C5a was titrated for optimal chemotaxis in a quantitative chemotaxis assay (11) and used at this concentration. Finally, in some studies a preparation of the synthetic chemotactic peptide f-MetLeu-Phe (kindly provided by Dr. Richard Freer ofthe Medical College of Virginia) was used at a concentration of 10 nM, which proved to be optimal for migration. In all cases, preexposure of PMN for 1 h to the concentrations of each chemotactic factor used in the study, followed by removal of the factor, deactivated these cells to the same factor later, as indicated by >50% inhibition in a quantitative chemotaxis assay (11) .
Chemiluminescence assay. PMN chemiluminescence was assayed as previously described in phosphate-buffered saline, pH 7.4, using zymosan that had been opsonized with fresh normal human serum as a stimulant (14) . When guinea pig PMN were used, zymosan was opsonized in the same manner with fresh guinea pig serum. PMN (5 x 106) were added in the dark to 2 mg of zymosan in a final volume of 1 ml. In some instances soluble factors were used to stimulate chemiluminescence, including 100 ,ug/ml Con A and 1.0 ,ug/ml phorbol myristate acetate (PMA) (Sigma Chemical Co., St. Louis, Mo.). When soluble stimuli were used, 10 nM luminol (Sigma Chemical Co.) was added to the mixture (15). 5 mg/ml PMA was prepared in dimethyl sulfoxide and diluted to the appropriate concentration in media just prior to testing. Assays were performed in 18-h dark-adapted Beckman poly Q vials (Beckman Instruments, Inc., Fullerton, Calif.), and analyzed in a nonrefrigeratedl Nuclear-Chicago B-scintillation counter (Nuclear-Chicago Corp., Des Plaines, Ill.) used out of coincidence with a window setting of 0, 10. Chemiluminescence, unless otherwise stated, was measured using 1-min counts at 6-min intervals for a minimum of 49 min. In each case, data are presented either as the chemiluminescence curve obtained or as the integrated area under the curve.
Superoxide anion assay. Superoxide anion generation was measured by the reduction of cytochrome c (16) . Cells to be tested were washed and resuspended in HBSS withouit phenol red to 1 x 107 PMN/ml. In some cases PMN were stimulated with normal serum-opsonized zymosan (2 mg) by mixing zymosan with 5 x 106 PMN, centrifuging for 45 s at 1,000 g, and resuspending in 1.5 ml of an 80-,uM cytochrome c solution prepared in HBSS without phenol red. Samples were then incubated for 5 min at 37°C. Unstimulated samples consisted of 5 x 106 PMN incubated in 1.5 ml of 80 ,tM cytochrome c, for 30 min at 37°C. The longer incubation period was essential for unstimulated cells to achieve a measurable release of superoxide anion. Superoxide anion release was assessed by determining the reduction of cytochrome c using spectrophotometric analysis at an optical density of 550 nM. The amount of cytochrome c reduced in each case was determined using a molar extinction coefficient of 2.1 x 104 and expressing the result as nanomoles of cytochrome c redIuced per 106 PMN.
Bactericidal assay. Bactericidal activity was assayed as previously described (17), using Escherichia coli K 12 as a target microorganismii. Mixtures containing -2.5 x 108 bacteria, 0.3 ml of opsonin (fresh normal serum diluted 1:3), and 5 x 106 PMN were adjusted to 1 ml with HBSS and used to assay PMN bactericidal activity. Mixtures were sampled after 0-, 30-, 60-, and 90-min incubations at 37°C by removing 0.001 ml of the mixture with a calibrated loop, diltuting this in 1 ml distilled water and subsequently mixing 0.1 ml of this suspension with Bacto antibiotic medium 2 agar (Difco Laboratories, Detroit, Mich.) in a pour plate. Pour plates were inctubated overnight and the number of viable bacteria determined by colony counts.
Determination of IgG and complement receptor positive PMN. PMN bearing IgG receptors were quantitated by both the rosette technique (17) and fluorescence microscopy, using the method of Winfield et al. (18) . PMN bearing complement receptors were quantitated using the rosette techniquie.
Rosette assays for IgG receptors were performed with bovine erythrocytes coated with rabbit IgG antibovine erythrocyte antibodies (17) . Complement receptor-bearing cells were determined using sheep erythrocytes coated with rabbit IgM anti-sheep erythrocyte antibody and human complement that had been absorbed with sheep erythrocytes (17) . PMN (2 x 106 in 0.2 ml) were mixed with 0.2 ml of a 1% solution of each of the erythrocyte preparations, centrifuged at 800 g for 4 min, and incubated at room temperature for 15 min. Cells were gently resuspended and the number of rosettes (three or more erythrocytes bound to a PMN) were quantitated in a hemocytometer and expressed as a percent of the total PMN present. Fewer than 3% rosettes were observed when uncoated bovine erythrocytes and uncoated or IgMcoated sheep erythrocytes were used.
IgG receptor-bearing PMN were also quantitated using a modification of the method of Winfield et al. (18) . Preparations of rabbit b4 allotype IgG and rabbit anti-b4 IgG were prepared by DEAE ion exchange chromatography (18) . PMN (2 x 106) were incuibated with 0.08 mg of rabbit b4 IgG at 4°C for 30 min. Cells were then washed twice and incubated for 30 min at 4°C with 40 ,ul of anti-b4 IgG which had been titrated to give optimal binding. Cells were again washed twice and subsequently incubated with fluorescein isothiocyanate-conjugated goat anti-rabbit IgG for 30 min at 4°C.
After an additional two washes, cells were observed by fluorescence microscopy and the number of positive cells quantitated. Fluorescence was inhibited by aggregated human IgG and no reduction in fluorescence was observed following absorption of the rabbit b4 or anti-b4 with human erythrocytes.
RESULTS
Enhanced PMN chemiluminescence after chemotaxis and chemotactic factor exposure. PMN from five individuals were incubated at 37°C for 3 h in either 5% FCS or a chemotactic factor preparation containing 5% FCS; or the PMN in 5% FCS were allowed to migrate through a 5-,tm pore-size membrane to the lower compartment of the enlarged chemotaxis chamber in response to chemotactic factor. The three cell preparations were then washed free ofchemotactic factor and tested for chemiluminescence in a zymosanstimulated system. Fig. 1 shows the mean chemiluminescence for each cell preparation using three dif- Table I were obtained using 100 ,ug/ml Con A and 1 ,ug/ml PMA. In all cases, the chemiluminescence of PMN migrating to chemotactic factor was greater than PMN incubated in chemotactic factor, which was greater than PMN incubated in media alone. This order was independent of the concentration of Con A or PMN, because this same order was maintained at 10-or 100-fold lower concentrations, although the peak response at lower concentrations was proportionally decreased.
Duration of enhanced chemiluminescence. Whether the enhanced chemiluminescence of PMN resulting from exposure to chemotactic factor repre- Enihantced bactericidal activity b1 chenmotactic factor-stiin ulalted neutrophils. Since both chemilumtiniescence aind superoxide anion production have been linked with bacterial killing (19, 20) preparations were then tested for bactericidal activity using E. coli as a target microorganism. As shown in Fig. 3 , the bactericidal activity of PMN exposed to chemotactic factor and of those that migrated in response to cheinotactic factor is significantly greater (P < 0.05 by a paired t test analysis) than that of control PMN. Although cells that migrated through the 5-,um pore-size membrane show a slightly greater bactericidal activity than cells simply incubated in chemotactic factor, the difference was not statistically significant by a paired t test with this sample size. Surface receptor analysis. It is feasible that modulation of surface opsonic receptors could account for the differences in the PMN responses described here. PMN preparations incubated for 3 h at 37°C in either 5% FCS or the casein-autologous serum mixture, as well as PMN that had migrated to this chemotactic preparation, were tested for Fc and complement receptor positive cells. Enhanced chemiluminescence in vivo by stimulated guinea pig peritoneal exudate neutrophils. To equate our in vitro findings with an in vivo model, guinea pigs were injected intraperitoneally with a 50%-saturated solution of casein in minimum essential media. 4 h later, PMN were removed from the peritoneal cavity, washed, and compared by chemiluminescence to peripheral blood PMN isolated from the same guinea pig. Results (Fig. 4) indicate that PMN responding in vivo to an inflammatory stimulus show enhanced chemiluminescence compared with PMN obtained from the peripheral blood ofthe same guinea pig. These data support the in vitro evidence presented previously and indicate that, in vivo, PMN migrating to an inflammatory foci show an enhanced stimulated chemilutminescence similar to those responding to a chemiotactic stimulus in vitro.
DISCUSSION
Many previous studies have shown that the direct addition of chemotactic factors to PMN preparations can stimulate neutrophil function and metabolism. These changes include the following: (a) chemotactic formylated peptides stimulate neuitrophil chemiluminescence (2); (b) exposure to C5a causes neuitrophil aggregation (3); (c) bacterial derived chemotactic factors, formyl-methionine-alanine, and trypsin-activated complemiient increase intracellular levels of cGMP (4); (d) f-Met-Leu-Phe and C5a increase assembly of microtubules (5, 6) ; (e) C5a, C3a, C567 (7), and formylated peptides (21) stimulate neutrophil degranulation (7); (f) f-Met-Leu-Phe, C5a, and bacterial derived chemotactic factors increase cell adherence (6, 8) ; and (g) f-Met-Leu-Phe stimutlates neutrophil production of stuperoxide anion (6, 9) . The present study demonstrates that P\IN that have been exposed to or have migrated to the chemotactic mixtture of caseiin and auitologous serumil are "activated" as indicated by enhanced chemiltuminescencee, superoxicle anIioIn productioni, and bactericidal activity. It is important to note that in this study cells were washed free of chemotactic factor in the media before testing since many of the previous studies mentioned demonstrate the effect of direct addition of chemotactic factor to PMN preparations. Althouigh washing the cells before testing removes chemotactic factor in the media, it does not mneani that all chemiotactic factor has been removed fromi the systemii since somie may be bound to cells or internalized. Although the effect of bound chemotactic factor on the assays performed is unknown, it 1hias been shown that, at least in the chemiluminiescenc e assay systemii, the response of PMN to the chemotactic factor f-Met-Leu-Phe peaks at 2 min andl drops off exponentially thereafter (2) . Becatuse PMN in this study were incubbated for 3 h with chemotactic facetor, the chemiltumiiinescenice of PMN stimuitilated by chemnotactic f:actor would have been far beyond its peak. In this study, enhanced stimulated chemiluminescence occurred with all tested chemotactic factors, including chemotactic C5 fragment, f-Met-Leu-Phe, and ac mixture of caseini aind fresh acutologouis serumi. Enhancemiienit was generally greater in cells that hald actutallly migrated through al 5-pmi pore-size clhemiiotaxis membrane, thain in those simply incubated for the samiie timne in chemotactic f'actor. Additional sttudies (Fig. 2) (Table III) . Because enhanced chemiluminescence of PMN exposed to chemotactic factor persisted for at least 2.5 h in the absence of chemotactic factor, it may be that activation itself involves some more permanent biologic changes, possibly in cell metabolism, cytoskeleton, or membrane structure. This would seem to preclude simply a short-term shift in intracellular regulators such as a cAMP or cGMP since elevated levels of cyclic nucleotides resulting from exposure of PMN to chemotactic factors and chemotactic modulators generally decrease within 1 h (4).
Previous studies (6, 8) have shown that chemotactic factors increase cell adherence, which could cause increased chemiluminescence and superoxide anion generation in systems stimulated with zymosan. Similarly, adherence is also essential to the bactericidal assay system. Although increased cell adherence in chemotactic factor-activated PMN may affect assays involving zymosan and bacteria, it should not affect assays mediated by soluble stimuli. Since chemnotactic factoractivated PMN show enhanced chemiluminescence in response to both Con A and PMN (Table I) , it is apparent that adherence is not the only mechanism involved in this enhancement. Likewise, experiments measuring superoxide anion generation by chemotactic factor-activated PMN in the absence of zymosan also indicate that these cells do not need a particulate stimulus to show enhanced superoxide anion production.
Studies by Gallin et al. (10) have shown that PMNdegranulating agents such as PMA, Con A, and the calcium ionophore A23187 increase PMN adherence and affect chemotactic factor binding under the proper conditions. These agents may act by exposing new membrane at the cell surface as a result ofthe exocytosis of specific granules, a process also known to occur when neutrophils are exposed to chemotactic factor (7, 21 A recent study by Cross and Lowell (25) showed that stimulated lymphocyte supernates also increase the bactericidal activity of PMN. Such an activation could be due to the presence of PMN chemotactic factors-known to be present in such preparations (26)-which could activate PMN in a manner similar to that observed here with other chemotactic factors. In addition, a report by Issekutz et al. (27) , published during the course of our study, indicates that PMN bactericidal activity for Staphylococcus aureus, E. coli, and Streptococcusfaecalis is increased by chemotactic factor exposure. Our study furthers their work and shows that (a) zymosan-, PMA-, and Con A-stimulated chemiluminescence, as well as zymosan-stimulated and unstimulated superoxide anion production, are increased in PMN that have migrated to or are exposed to chemotactic factor in a system where cells are washed free of exogenious chemotactic factor; (b) this enhanced activity persists for at least 2.5 h in the absence of chemotactic factor; (c) enhanced PMN chemiluminescence is also observed with casein-elicited guinea pig PMN in vivo; and (d) enhanced PMN function due to chemotactic factor exposure is not the result of an increased number of Fc or comnplement receptor positive PMN, as determined by the methods employed here.
